Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

392 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase IIIb safety results from an expanded-access protocol of talimogene laherparepvec for patients with unresected, stage IIIB-IVM1c melanoma.
Chesney J, Awasthi S, Curti B, Hutchins L, Linette G, Triozzi P, Tan MCB, Brown RE, Nemunaitis J, Whitman E, Windham C, Lutzky J, Downey GF, Batty N, Amatruda T. Chesney J, et al. Among authors: nemunaitis j. Melanoma Res. 2018 Feb;28(1):44-51. doi: 10.1097/CMR.0000000000000399. Melanoma Res. 2018. PMID: 29176501 Clinical Trial.
Phase 2 trial of Allovectin-7 in advanced metastatic melanoma.
Gonzalez R, Hutchins L, Nemunaitis J, Atkins M, Schwarzenberger PO. Gonzalez R, et al. Among authors: nemunaitis j. Melanoma Res. 2006 Dec;16(6):521-6. doi: 10.1097/01.cmr.0000232299.44902.41. Melanoma Res. 2006. PMID: 17119453 Clinical Trial.
Clinical Activity, Tolerability, and Long-Term Follow-Up of Durvalumab in Patients With Advanced NSCLC.
Antonia SJ, Balmanoukian A, Brahmer J, Ou SI, Hellmann MD, Kim SW, Ahn MJ, Kim DW, Gutierrez M, Liu SV, Schöffski P, Jäger D, Jamal R, Jerusalem G, Lutzky J, Nemunaitis J, Calabrò L, Weiss J, Gadgeel S, Bhosle J, Ascierto PA, Rebelatto MC, Narwal R, Liang M, Xiao F, Antal J, Abdullah S, Angra N, Gupta AK, Khleif SN, Segal NH. Antonia SJ, et al. Among authors: nemunaitis j. J Thorac Oncol. 2019 Oct;14(10):1794-1806. doi: 10.1016/j.jtho.2019.06.010. Epub 2019 Jun 20. J Thorac Oncol. 2019. PMID: 31228626 Free article. Clinical Trial.
Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studies.
Nemunaitis J, Poole C, Primrose J, Rosemurgy A, Malfetano J, Brown P, Berrington A, Cornish A, Lynch K, Rasmussen H, Kerr D, Cox D, Millar A. Nemunaitis J, et al. Clin Cancer Res. 1998 May;4(5):1101-9. Clin Cancer Res. 1998. PMID: 9607566 Clinical Trial.
Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study.
Cunningham CC, Chada S, Merritt JA, Tong A, Senzer N, Zhang Y, Mhashilkar A, Parker K, Vukelja S, Richards D, Hood J, Coffee K, Nemunaitis J. Cunningham CC, et al. Among authors: nemunaitis j. Mol Ther. 2005 Jan;11(1):149-59. doi: 10.1016/j.ymthe.2004.09.019. Mol Ther. 2005. PMID: 15585416 Free article. Clinical Trial.
Herpes simplex virus 1 (HSV-1) for cancer treatment.
Shen Y, Nemunaitis J. Shen Y, et al. Among authors: nemunaitis j. Cancer Gene Ther. 2006 Nov;13(11):975-92. doi: 10.1038/sj.cgt.7700946. Epub 2006 Apr 7. Cancer Gene Ther. 2006. PMID: 16604059 Review.
392 results